Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fort Wayne, IN
NPI
1518915800
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7900 W Jefferson Blvd Ste 201
Fort Wayne, IN, 46804
Phone (260) 432-2297
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
717 services
Medicare patients, 2024
256
Average age 72
Drug cost, 2024
$3.0M
3,663 prescriptions
Company payments, 2025
$2,581
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by H S Beyer was code 99214 (office e&m - established), 311 times for 178 patients. In total H S Beyer billed 717 services in 17 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 311 | 178 | $80.92 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 129 | 87 | $11.74 | $1,514 |
| 99204 Office E&M - New | Office | 76 | 76 | $113.39 | $8,617 |
| 95251 Test - Miscellaneous | Office | 75 | 38 | $24.54 | $1,840 |
| 99215 Office E&M - Established | Office | 63 | 52 | $113.52 | $7,152 |
| 99213 Office E&M - Established | Office | 21 | 21 | $49.83 | $1,046 |
By year: 2022 $69K for 2,161 services; 2023 $54K for 1,098 services; 2024 $48K for 717 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 71 | 54 | $8.16 | $580 |
| 84443 Clinical Chemistry | 43 | 34 | $16.46 | $708 |
| 83036 Blood Count | 20 | 15 | $9.52 | $190 |
| 84439 Clinical Chemistry | 18 | 15 | $8.84 | $159 |
| 80053 Clinical Chemistry | 13 | 13 | $9.55 | $124 |
Medicare prescription drug claims, 2024
In 2024, the drug H S Beyer prescribed most often to Medicare patients was Ozempic (Semaglutide), with 499 prescriptions and refills. In total H S Beyer wrote 3,663 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 499 | 708 | 104 | $677K |
| Levothyroxine Sodium Generic | 490 | 1,360 | 143 | $3,998 |
| Mounjaro Tirzepatide | 220 | 262 | 45 | $280K |
| Metformin Hcl Er Metformin Hcl | 136 | 379 | 52 | $917 |
| Metformin Hcl Generic | 121 | 336 | 39 | $858 |
| Methimazole Generic | 108 | 269 | 30 | $699 |
| Synthroid Levothyroxine Sodium | 100 | 280 | 31 | $8,643 |
| Novolog Flexpen Insulin Aspart | 83 | 140 | 24 | $19K |
| Rosuvastatin Calcium Generic | 78 | 231 | 31 | $586 |
| Atorvastatin Calcium Generic | 77 | 223 | 28 | $501 |
| Pioglitazone Hcl Generic | 71 | 208 | 29 | $579 |
| Humalog Kwikpen U-100 Insulin Lispro | 63 | 142 | 24 | $20K |
| Alendronate Sodium Generic | 62 | 152 | 19 | $509 |
| Testosterone Cypionate Generic | 58 | 114 | 18 | $4,689 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 58 | 119 | 20 | $8,768 |
Brand drugs: 1,893 claims; generic drugs: 1,593 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid H S Beyer $2,581 ($2,581 in general payments such as food, travel and fees) from 25 companies. The largest payer was Medtronic, Inc. with $946.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 2 | $946 |
| Lilly USA, LLC LLY | 18 | $387 |
| Amgen Inc. AMGN | 8 | $185 |
| Sanofi-Aventis U.S. LLC SNY | 9 | $139 |
| Esteve Pharmaceuticals LLC | 1 | $124 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $118 |
| Abbott Laboratories ABT | 3 | $68.22 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $68.06 |
| Kyowa Kirin, Inc. 4151.T | 3 | $61.5 |
| Xeris Pharmaceuticals, Inc. | 3 | $48.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.